Dr. Terry Pearson

Dr. Pearson is a scientist, entrepreneur and emeritus professor from the Biochemistry and Microbiology Department at the University of Victoria.
Having obtained his Ph.D. in immunology from the University of British Columbia, Dr. Pearson later joined the MRC Laboratory of Molecular Biology in Cambridge, England.

Dr. Pearson worked with Nobel Prize Laureates Georges Kohler and Cesar Milstein, during the development of monoclonal antibody technology, leading to the first commercial monoclonal antibody. Terry took the technology to Africa and subsequently to Canada and helped to establish the base for many scientific and therapeutic applications involving the exploitation of these reagents. Today, the monoclonal antibody market exceeds 150 billion USD, a figure projected to reach more than 451 billion USD by 2028.

As co-founder and CSO of SISCAPA Assay Technologies Inc., Dr. Pearson helped lead the development of immuno-mass spectrometric technology for measurement of biomarkers in health and disease. He has received several awards for his contribution to science, including the Inaugural Award for Excellence in Science Teaching, the Craigdarroch Gold Medal for Career Achievement and the Legacy Award for Research from the University of Victoria.